1. Home
  2. KOPN vs ENTX Comparison

KOPN vs ENTX Comparison

Compare KOPN & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$2.40

Market Cap

424.9M

Sector

Technology

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.88

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOPN
ENTX
Founded
1984
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.9M
142.0M
IPO Year
1992
2018

Fundamental Metrics

Financial Performance
Metric
KOPN
ENTX
Price
$2.40
$1.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.25
$10.00
AVG Volume (30 Days)
3.3M
85.0K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,602,295.00
$124,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$43.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.02
25.25
52 Week Low
$0.71
$1.50
52 Week High
$4.16
$3.22

Technical Indicators

Market Signals
Indicator
KOPN
ENTX
Relative Strength Index (RSI) 42.73 27.62
Support Level $2.28 $2.07
Resistance Level $2.65 $2.22
Average True Range (ATR) 0.20 0.16
MACD -0.00 -0.03
Stochastic Oscillator 22.22 0.00

Price Performance

Historical Comparison
KOPN
ENTX

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: